Fundz

Norris Medicines Appoints Iqual Ismail Patel as Chief Financial Officer

PRIVATEJul 30, 2026

Position

Chief Financial Officer

Company

Norris Medicines

Iqual Ismail Patel
BiotechnologyHealth CarePharmaceutical

Description

Norris Medicines has appointed Iqual Ismail Patel as its new Chief Financial Officer, effective July 30, 2026. This hiring fills a critical executive vacancy that had persisted for several months, restoring essential financial leadership.

Quick answer

Norris Medicines Appoints Iqual Ismail Patel as Chief Financial Officer (July 30, 2026).

Who is the new Chief Financial Officer at Norris Medicines?
Norris Medicines named Iqual Ismail Patel Chief Financial Officer, announced July 30, 2026.
What did Norris Medicines announce on July 30, 2026?
Norris Medicines has appointed Iqual Ismail Patel as its new Chief Financial Officer, effective July 30, 2026. This hiring fills a critical executive vacancy that had persisted for several months, restoring essential financial leadership.
What does Norris Medicines do?
Norris Medicines is a micro-cap company operating in the small-scale generic drug formulation sector in India.
Which similar companies made leadership changes around the same time?
Nasus Pharma (July 28, 2026), Helus Pharma (August 3, 2026), Petauri (July 23, 2026) and Cipla (July 23, 2026) also announced leadership changes within 45 days of Norris Medicines.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Norris Medicines, and when

A new leader at Norris Medicines brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Norris Medicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Norris Medicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Norris Medicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Norris Medicines

About

Norris Medicines is a micro-cap company operating in the small-scale generic drug formulation sector in India. The company is currently navigating operational hurdles and profitability pressures. They focus on financial compliance and planning within a highly competitive market. Their market capitalization stands at ₹15.5 cr.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Norris Medicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Norris Medicines's next move

Learn about Strategic plan

Norris Medicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.